Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
Recruiting now · Phase 3
Conditions studied: Anesthesia, Propofol Adverse Reaction, Etomidate Adverse Reaction, Anesthesia Complication, Anesthesia; Adverse Effect, Anesthesia; Reaction
In brief
The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).
Key facts
- Study ID
- NCT05358535
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 200
- Starts
- 2022-09-19
- Expected to finish
- 2027-03-01
- Last updated by the study team
- 2026-01-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (age ≥18 years old)
- Having endoscopic procedure at CUH with anesthesia
- ASA 3 or above
- Ejection Fraction test result available
You may not qualify if…
- Known allergies or adverse reactions to study drugs or study drug components or preservatives
- Patient refusal
- Clinician refusal
- Documented cognitive impairments precluding subject ability to consent for themselves unless a surrogate documented legally acceptable decision maker consents for patient participation
- Prisoner or incarcerated or patients held by law enforcement officials in custody
- Pregnancy or patient refusal for pregnancy testing or screening (standard UTSW policy and protocol requires pregnancy testing for appropriate patients prior to anesthesia)
Where it is running
- Clements University Hospital — Dallas, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.